| Product Code: ETC8967597 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Romania Clinical Oncology NGS Market Overview |
3.1 Romania Country Macro Economic Indicators |
3.2 Romania Clinical Oncology NGS Market Revenues & Volume, 2021 & 2031F |
3.3 Romania Clinical Oncology NGS Market - Industry Life Cycle |
3.4 Romania Clinical Oncology NGS Market - Porter's Five Forces |
3.5 Romania Clinical Oncology NGS Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.6 Romania Clinical Oncology NGS Market Revenues & Volume Share, By Workflow, 2021 & 2031F |
3.7 Romania Clinical Oncology NGS Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Romania Clinical Oncology NGS Market Revenues & Volume Share, By End-use, 2021 & 2031F |
4 Romania Clinical Oncology NGS Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing incidence of cancer in Romania |
4.2.2 Technological advancements in Next-Generation Sequencing (NGS) technology |
4.2.3 Growing awareness and adoption of personalized medicine in clinical oncology |
4.3 Market Restraints |
4.3.1 High cost associated with NGS testing |
4.3.2 Lack of reimbursement policies for NGS testing in clinical oncology |
5 Romania Clinical Oncology NGS Market Trends |
6 Romania Clinical Oncology NGS Market, By Types |
6.1 Romania Clinical Oncology NGS Market, By Technology |
6.1.1 Overview and Analysis |
6.1.2 Romania Clinical Oncology NGS Market Revenues & Volume, By Technology, 2021- 2031F |
6.1.3 Romania Clinical Oncology NGS Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Romania Clinical Oncology NGS Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Romania Clinical Oncology NGS Market Revenues & Volume, By Targeted Sequencing & Resequencing Centrifuges, 2021- 2031F |
6.2 Romania Clinical Oncology NGS Market, By Workflow |
6.2.1 Overview and Analysis |
6.2.2 Romania Clinical Oncology NGS Market Revenues & Volume, By Pre-Sequencing, 2021- 2031F |
6.2.3 Romania Clinical Oncology NGS Market Revenues & Volume, By Sequencing, 2021- 2031F |
6.2.4 Romania Clinical Oncology NGS Market Revenues & Volume, By Data Analysis, 2021- 2031F |
6.3 Romania Clinical Oncology NGS Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Romania Clinical Oncology NGS Market Revenues & Volume, By Screening, 2021- 2031F |
6.3.3 Romania Clinical Oncology NGS Market Revenues & Volume, By Companion Diagnostics, 2021- 2031F |
6.3.4 Romania Clinical Oncology NGS Market Revenues & Volume, By Other Diagnostics, 2021- 2031F |
6.4 Romania Clinical Oncology NGS Market, By End-use |
6.4.1 Overview and Analysis |
6.4.2 Romania Clinical Oncology NGS Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Romania Clinical Oncology NGS Market Revenues & Volume, By Clinics, 2021- 2031F |
6.4.4 Romania Clinical Oncology NGS Market Revenues & Volume, By Laboratories, 2021- 2031F |
7 Romania Clinical Oncology NGS Market Import-Export Trade Statistics |
7.1 Romania Clinical Oncology NGS Market Export to Major Countries |
7.2 Romania Clinical Oncology NGS Market Imports from Major Countries |
8 Romania Clinical Oncology NGS Market Key Performance Indicators |
8.1 Adoption rate of NGS technology in clinical oncology |
8.2 Number of clinical trials utilizing NGS in oncology research |
8.3 Rate of integration of NGS data into clinical decision-making processes |
8.4 Number of partnerships between healthcare providers and NGS technology companies in Romania |
8.5 Percentage of oncologists trained in NGS technology and its applications |
9 Romania Clinical Oncology NGS Market - Opportunity Assessment |
9.1 Romania Clinical Oncology NGS Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.2 Romania Clinical Oncology NGS Market Opportunity Assessment, By Workflow, 2021 & 2031F |
9.3 Romania Clinical Oncology NGS Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Romania Clinical Oncology NGS Market Opportunity Assessment, By End-use, 2021 & 2031F |
10 Romania Clinical Oncology NGS Market - Competitive Landscape |
10.1 Romania Clinical Oncology NGS Market Revenue Share, By Companies, 2024 |
10.2 Romania Clinical Oncology NGS Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here